• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估多发性硬化症患者的工作生产力损失及其与工作生产力损失相关的因素:来自澳大利亚代表性多发性硬化症患者样本的研究。

Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis.

机构信息

Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.

Department of Management, Monash University, Narre Warren, VIC, Australia.

出版信息

Mult Scler. 2019 Jun;25(7):994-1004. doi: 10.1177/1352458518781971. Epub 2018 Jun 18.

DOI:10.1177/1352458518781971
PMID:29911469
Abstract

BACKGROUND

Little is known about the work productivity loss in multiple sclerosis (MS).

OBJECTIVES

To quantify the MS-related work productivity loss and to compare factors associated with labour force participation and work productivity loss.

METHODS

Participants were from the Australian MS Longitudinal Study. MS-related work productivity loss included absenteeism (time missed from work) and presenteeism (reduced productivity while working). Data were analysed using log-binomial and Cragg hurdle regression.

RESULTS

Among 740 MS employees, 56% experienced any work productivity loss due to MS in the past 4  weeks. The mean total work productivity loss was 2.5  days (14.2% lost productive time), absenteeism 0.6  days (3.4%) and presenteeism 1.9  days (10.8%)), leading to AU$6767 (US$4985, EURO€4578) loss per person annually. Multivariable analyses showed that work productivity was determined most strongly by symptoms, particularly 'fatigue and cognitive symptoms' and 'pain and sensory symptoms', while older age, and lower education level were also predictive of not being in the labour force.

CONCLUSION

MS-related presenteeism was three times higher than absenteeism, highlighting the importance of presenteeism being included in employment outcomes. The dominance of symptom severity as predictors of both work participation and productivity loss emphasises the need for improved management of symptoms.

摘要

背景

多发性硬化症(MS)导致的工作生产力损失知之甚少。

目的

量化 MS 相关工作生产力损失,并比较与劳动力参与和工作生产力损失相关的因素。

方法

参与者来自澳大利亚多发性硬化症纵向研究。MS 相关工作生产力损失包括缺勤(工作缺勤时间)和在职工作效率降低(生产力降低)。使用对数二项式和 Cragg 障碍回归分析数据。

结果

在 740 名 MS 员工中,56%的人在过去 4 周内因 MS 而出现任何工作生产力损失。平均总工作生产力损失为 2.5 天(14.2%的工作时间损失),缺勤 0.6 天(3.4%)和在职工作效率降低 1.9 天(10.8%)),导致每人每年损失 6767 澳元(4985 美元,4578 欧元)。多变量分析表明,工作生产力主要由症状决定,特别是“疲劳和认知症状”和“疼痛和感觉症状”,而年龄较大和教育程度较低也与不在劳动力中有关。

结论

MS 相关的在职工作效率降低是缺勤的三倍,这凸显了将在职工作效率降低纳入就业结果的重要性。症状严重程度作为工作参与和生产力损失的预测因素的主导地位强调了需要改善症状管理。

相似文献

1
Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis.评估多发性硬化症患者的工作生产力损失及其与工作生产力损失相关的因素:来自澳大利亚代表性多发性硬化症患者样本的研究。
Mult Scler. 2019 Jun;25(7):994-1004. doi: 10.1177/1352458518781971. Epub 2018 Jun 18.
2
Estimating the impact of work difficulties, work self-efficacy and work psychological safety on MS-related work productivity loss.评估工作困难、工作自我效能和工作心理安全感对 MS 相关工作生产力损失的影响。
Mult Scler. 2022 Oct;28(12):1983-1996. doi: 10.1177/13524585221097573. Epub 2022 Jun 2.
3
Changes in multiple sclerosis symptoms are associated with changes in work productivity of people living with multiple sclerosis.多发性硬化症症状的变化与多发性硬化症患者的工作生产力变化有关。
Mult Scler. 2021 Nov;27(13):2093-2102. doi: 10.1177/1352458521994557. Epub 2021 Feb 16.
4
Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life.复发型多发性硬化症患者的工作生产力:与残疾、抑郁、疲劳、焦虑、认知和健康相关生活质量的关联。
Value Health. 2012 Dec;15(8):1029-35. doi: 10.1016/j.jval.2012.07.010. Epub 2012 Oct 25.
5
Work productivity trajectories of Australians living with multiple sclerosis: A group-based modelling approach.澳大利亚多发性硬化症患者的工作生产力轨迹:基于群组的建模方法。
Mult Scler Relat Disord. 2021 Sep;54:103131. doi: 10.1016/j.msard.2021.103131. Epub 2021 Jul 10.
6
Self-reported work productivity in people with multiple sclerosis and its association with mental and physical health.多发性硬化症患者的自我报告工作生产力及其与心理健康和身体健康的关系。
Disabil Rehabil. 2022 Nov;44(23):7096-7105. doi: 10.1080/09638288.2021.1981468. Epub 2021 Oct 5.
7
The Effect of Endometriosis Symptoms on Absenteeism and Presenteeism in the Workplace and at Home.子宫内膜异位症症状对工作场所和家庭缺勤和出勤的影响。
J Manag Care Spec Pharm. 2017 Jul;23(7):745-754. doi: 10.18553/jmcp.2017.23.7.745.
8
Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32 748 women.因月经相关症状导致的生产力损失:一项针对 32748 名女性的全国性横断面调查。
BMJ Open. 2019 Jun 27;9(6):e026186. doi: 10.1136/bmjopen-2018-026186.
9
Risk factors associated with reduced work productivity among people with chronic knee pain.与慢性膝痛患者工作生产力降低相关的风险因素。
Osteoarthritis Cartilage. 2013 Sep;21(9):1160-9. doi: 10.1016/j.joca.2013.07.005.
10
Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA study.工作参与度在各国的脊柱关节炎中:来自 ASAS-COMOSPA 研究的分析。
Ann Rheum Dis. 2018 Sep;77(9):1303-1310. doi: 10.1136/annrheumdis-2018-213464. Epub 2018 Jun 2.

引用本文的文献

1
Impact of Natalizumab on Productivity and Ability to Work in Patients with Multiple Sclerosis in France: The TITAN Study.那他珠单抗对法国多发性硬化症患者生产力及工作能力的影响:TITAN研究
Neurol Ther. 2025 Jun;14(3):895-909. doi: 10.1007/s40120-025-00725-x. Epub 2025 Apr 10.
2
Impact of sleep quality on health-related quality of life domains and the mediating effects of symptoms in people with multiple sclerosis.睡眠质量对多发性硬化症患者健康相关生活质量领域的影响及症状的中介作用
Qual Life Res. 2025 Feb;34(2):563-575. doi: 10.1007/s11136-024-03836-4. Epub 2024 Nov 13.
3
Emotional labor, fatigue, and presenteeism in Chinese nurses: the role of organizational identification.
中国护士的情绪劳动、疲劳与出勤主义:组织认同的作用
BMC Nurs. 2024 Sep 20;23(1):673. doi: 10.1186/s12912-024-02351-8.
4
Protocol for a pragmatic randomised controlled feasibility study of : an online intervention for Australians with MS who are employed.一项实用随机对照可行性研究的方案:一项针对澳大利亚就业多发性硬化症患者的在线干预。
BMJ Open. 2024 May 20;14(5):e079644. doi: 10.1136/bmjopen-2023-079644.
5
Impact of Long COVID on productivity and informal caregiving.长新冠对生产力和非正规照护的影响。
Eur J Health Econ. 2024 Sep;25(7):1095-1115. doi: 10.1007/s10198-023-01653-z. Epub 2023 Dec 26.
6
Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada.在加拿大,用奥法妥木单抗治疗复发缓解型多发性硬化症的成本-后果分析。
J Comp Eff Res. 2023 Sep;12(9):e220175. doi: 10.57264/cer-2022-0175. Epub 2023 Aug 22.
7
Changes in employment status over time in multiple sclerosis following a first episode of central nervous system demyelination, a Markov multistate model study.多发性硬化症首次中枢神经系统脱髓鞘后随时间推移的就业状态变化:一项马尔可夫多状态模型研究。
Eur J Neurol. 2024 Jan;31(1):e16016. doi: 10.1111/ene.16016. Epub 2023 Aug 13.
8
Employment status, productivity loss, and associated factors among people with multiple sclerosis.多发性硬化症患者的就业状况、生产力损失及其相关因素。
Mult Scler. 2023 Jun;29(7):866-874. doi: 10.1177/13524585231164295. Epub 2023 Apr 15.
9
Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand.采用 EQ-5D-5L 量表评估新西兰多发性硬化症患者疾病修正治疗政策对生活质量的影响。
Eur J Health Econ. 2023 Aug;24(6):939-950. doi: 10.1007/s10198-022-01518-x. Epub 2022 Sep 23.
10
Work difficulties in people with multiple sclerosis: The role of anxiety, depression and coping.多发性硬化症患者的工作困难:焦虑、抑郁及应对方式的作用
Mult Scler J Exp Transl Clin. 2022 Sep 4;8(3):20552173221116282. doi: 10.1177/20552173221116282. eCollection 2022 Jul-Sep.